FOXO TECHNOLOGIES INC. Paid-in-Kind Interest
FOXO TECHNOLOGIES INC. (FOXO) reported Paid-in-Kind Interest of $939.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. paid-in-kind interest for the quarter ending 2026-06-30 was $513.88K, a 119.76% increase year-over-year.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for the quarter ending 2026-03-31 was $425.78K, a 101.23% increase year-over-year.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for the quarter ending 2025-12-31 was $232.64K, a 16.76% decline year-over-year.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for the quarter ending 2025-09-30 was $238.45K, a 9.89% decline year-over-year.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for fiscal 2025 was $916.51K, a 12.53% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for fiscal 2024 was $1.05M, a 70.13% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for fiscal 2023 was $615.84K, a 373.72% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. paid-in-kind interest for fiscal 2022 was $130.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 3 month as first filed | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 6 month as first filed | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 9 month as first filed | Paid-in-Kind Interest 12 month | Paid-in-Kind Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $513.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $939.66K 10-Q · filed 2026-08-14 | $1.17M derived: sum of 3 quarters · filed 2026-08-14 | $1.41M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $425.78K 10-Q · filed 2026-05-15 | $658.42K derived: sum of 2 quarters · filed 2026-05-15 | $896.87K derived: sum of 3 quarters · filed 2026-05-15 | $1.13M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $232.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $471.08K derived: sum of 2 quarters · filed 2026-04-15 | $704.92K derived: sum of 3 quarters · filed 2026-08-14 | $916.51K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $238.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $472.28K derived: sum of 2 quarters · filed 2026-08-14 | $683.87K 10-Q · filed 2025-11-10 | $963.37K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $233.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $445.43K 10-Q · filed 2026-08-14 | $70.59K 10-Q · filed 2025-08-19 | $724.92K derived: sum of 3 quarters · filed 2026-08-14 | $989.54K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $211.59K 10-Q · filed 2026-05-15 | $70.59K 10-Q · filed 2025-05-20 | $491.09K derived: sum of 2 quarters · filed 2026-05-15 | $755.70K derived: sum of 3 quarters · filed 2026-05-15 | $1.00M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $279.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $544.11K derived: sum of 2 quarters · filed 2026-04-15 | $789.48K derived: sum of 3 quarters · filed 2026-04-15 | $1.05M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $264.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $509.99K derived: sum of 2 quarters · filed 2025-11-10 | $768.25K 10-Q · filed 2025-11-10 | $768.00K 10-Q · filed 2024-11-19 | $965.09K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $245.37K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $503.63K 10-Q · filed 2025-08-19 | $504.00K 10-Q · filed 2024-08-19 | $700.47K derived: sum of 3 quarters · filed 2025-08-19 | $844.47K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | $258.26K 10-Q/A · filed 2025-08-19 | $258.00K 10-Q · filed 2024-06-28 | $455.10K derived: sum of 2 quarters · filed 2025-08-19 | $599.10K derived: sum of 3 quarters · filed 2025-08-19 | $739.10K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $196.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $340.84K derived: sum of 2 quarters · filed 2025-04-15 | $480.84K derived: sum of 3 quarters · filed 2025-04-15 | $615.84K 10-K · filed 2025-04-15 | $616.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $284.00K derived: sum of 2 quarters · filed 2024-11-19 | $419.00K 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $275.00K 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | $135.00K 10-Q · filed 2024-06-28 | |||||||
| 2022-12-31 | $130.00K 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |